In a study published in Nature Neuroscience, researchers from Tiziana Life Sciences Ltd. and collaborators investigated the potential of nasal delivery of the CD3 foralumab to reduce neuroinflammation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback